Your browser doesn't support javascript.
Progression from palindromic rheumatism to rheumatoid arthritis after COVID-19 vaccination.
Bansal, Pankaj; Sonani, Bhavin; Aslam, Fawad.
  • Bansal P; Mayo Clinic Health System.
  • Sonani B; Department of Internal Medicine. HSHS St John's Hospital.
  • Aslam F; Mayo Clinic Arizona.
ARP Rheumatol ; 1(1): 100-101, 2022.
Article in English | MEDLINE | ID: covidwho-1870620
ABSTRACT
Infections including COVID-19 infection are associated with immune overactivation and hyperinflammation, and cases of incident inflammatory arthritis after COVID-19 and other respiratory viral infections have been reported. Theoretical concerns of autoimmunity due to molecular mimicry exist with vaccines including vaccines for COVID-19, and rare cases of flares of underlying chronic inflammatory disorders such as systemic lupus erythematosus have been reported after COVID-19 vaccination. Here we present the case of a patient with a 7-year history of well-controlled palindromic rheumatism who developed rheumatoid arthritis 2 weeks after vaccination for COVID-19. This is the first such case to our knowledge, and further studies can elaborate on the risk of autoimmunity due to COVID-19 vaccines if one exists. Given the overall safety and efficacy of COVID-19 vaccines, the proven benefits of vaccinating vulnerable patients with autoimmune disorders outweigh this potential theoretical risk of autoimmune disease flare, and vaccinations in this at-risk population shall be strongly encouraged.
Subject(s)
Search on Google
Collection: International databases Database: MEDLINE Main subject: Arthritis, Rheumatoid / Autoimmune Diseases / Vaccines / COVID-19 Type of study: Case report / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: ARP Rheumatol Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: International databases Database: MEDLINE Main subject: Arthritis, Rheumatoid / Autoimmune Diseases / Vaccines / COVID-19 Type of study: Case report / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: ARP Rheumatol Year: 2022 Document Type: Article